Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1988 1
1991 1
2002 1
2007 2
2008 1
2009 2
2010 1
2011 5
2012 5
2013 3
2014 3
2015 3
2016 4
2017 3
2018 3
2019 3
2020 5
2021 12
2022 9
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for simona prior
Search for Simona Priora instead (1 results)
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
COVIDSurg Collaborative; GlobalSurg Collaborative. COVIDSurg Collaborative, et al. Anaesthesia. 2022 Jan;77(1):28-39. doi: 10.1111/anae.15563. Epub 2021 Aug 24. Anaesthesia. 2022. PMID: 34428858 Free PMC article.
Since surgical patients are already at higher risk of venous thromboembolism than general populations, this study aimed to determine if patients with peri-operative or prior SARS-CoV-2 were at further increased risk of venous thromboembolism. ...
Since surgical patients are already at higher risk of venous thromboembolism than general populations, this study aimed to determine if pati …
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
De Laurentiis M, Borstnar S, Campone M, Warner E, Bofill JS, Jacot W, Dent S, Martin M, Ring A, Cottu P, Lu J, Ciruelos E, Azim HA, Chatterjee S, Zhou K, Wu J, Menon-Singh L, Zamagni C. De Laurentiis M, et al. Breast Cancer Res Treat. 2021 Oct;189(3):689-699. doi: 10.1007/s10549-021-06334-0. Epub 2021 Aug 19. Breast Cancer Res Treat. 2021. PMID: 34414532 Free PMC article. Clinical Trial.
PURPOSE: CompLEEment-1 is a phase 3b trial in an expanded patient population with hormone receptor-positive (HR +), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC), the largest current trial of cyclin-dependent kinase 4 and 6 inhibitors in A …
PURPOSE: CompLEEment-1 is a phase 3b trial in an expanded patient population with hormone receptor-positive (HR +), human epidermal growth f …
Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events: A 1-Year Follow-up.
Nguyen TN, Qureshi MM, Klein P, Yamagami H, Mikulik R, Czlonkowska A, Abdalkader M, Sedova P, Sathya A, Lo HC, Mansour OY, Vanguru HR, Lesaine E, Tsivgoulis G, Loochtan AI, Demeestere J, Uchino K, Inoa V, Goyal N, Charidimou A, Siegler JE, Yaghi S, Aguiar de Sousa D, Mohammaden MH, Haussen DC, Kristoffersen ES, Lereis VP, Scollo SD, Campbell BCV, Ma A, Thomas JO, Parsons MW, Singhal S, Slater LA, Tomazini Martins R, Enzinger C, Gattringer T, Rahman A, Bonnet T, Ligot N, De Raedt S, Lemmens R, Vanacker P, Vandervorst F, Conforto AB, Hidalgo RCT, de Oliveira Neves L, Martins RT, Mora Cuervo DL, Rebello LC, Santiago IB, Lameirinhas da Silva I, Sakelarova T, Kalpachki R, Alexiev F, Catanese L, Cora EA, Goyal M, Hill MD, Kelly ME, Khosravani H, Lavoie P, Peeling L, Pikula A, Rivera R, Chen HS, Chen Y, Huo X, Miao Z, Yang S, Bedekovic MR, Bralic M, Budincevic H, Corredor-Quintero AB, Lara-Sarabia OE, Cabal M, Tenora D, Fibrich P, Herzig R, Hlaváčová H, Hrabanovska E, Hlinovsky D, Jurak L, Kadlcikova J, Karpowicz I, Klecka L, Kovar M, Lauer D, Neumann J, Palouskova H, Reiser M, Rekova P, Rohan V, Skoda O, Škorňa M, Sobotková L, Sramek M, Zakova L, Christensen H, Drenck N, Iversen HK, Tru… See abstract for full author list ➔ Nguyen TN, et al. Neurology. 2023 Jan 24;100(4):e408-e421. doi: 10.1212/WNL.0000000000201426. Epub 2022 Oct 18. Neurology. 2023. PMID: 36257718 Free PMC article.
DISCUSSION: There was a global decline and shift to lower-volume centers of stroke admission volumes, ICH volumes, and IVT volumes during the 1st year of the COVID-19 pandemic compared with the prior year. Mechanical thrombectomy volumes were preserved. These results sugge …
DISCUSSION: There was a global decline and shift to lower-volume centers of stroke admission volumes, ICH volumes, and IVT volumes during th …
Complex evolutionary history of felid anelloviruses.
Kraberger S, Serieys LE, Richet C, Fountain-Jones NM, Baele G, Bishop JM, Nehring M, Ivan JS, Newkirk ES, Squires JR, Lund MC, Riley SP, Wilmers CC, van Helden PD, Van Doorslaer K, Culver M, VandeWoude S, Martin DP, Varsani A. Kraberger S, et al. Virology. 2021 Oct;562:176-189. doi: 10.1016/j.virol.2021.07.013. Epub 2021 Jul 29. Virology. 2021. PMID: 34364185 Free article.
Anellovirus infections are highly prevalent in mammals, however, prior to this study only a handful of anellovirus genomes had been identified in members of the Felidae family. ...
Anellovirus infections are highly prevalent in mammals, however, prior to this study only a handful of anellovirus genomes had been i …
Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes.
De Matteis E, Sacco S, Ornello R. De Matteis E, et al. Ther Clin Risk Manag. 2022 Apr 5;18:359-378. doi: 10.2147/TCRM.S263825. eCollection 2022. Ther Clin Risk Manag. 2022. PMID: 35411146 Free PMC article. Review.
Randomized clinical trials proved the superiority of erenumab to placebo in a strictly selected population, while real-world studies confirmed treatment efficacy in more severe forms of disease - most patients suffered from chronic migraine with medication overuse headache, had …
Randomized clinical trials proved the superiority of erenumab to placebo in a strictly selected population, while real-world studies confirm …
Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis.
Sparaco M, Carbone L, Landi D, Ingrasciotta Y, Di Girolamo R, Vitturi G, Marfia GA, Alviggi C, Bonavita S. Sparaco M, et al. CNS Drugs. 2023 Oct;37(10):849-866. doi: 10.1007/s40263-023-01036-1. Epub 2023 Sep 7. CNS Drugs. 2023. PMID: 37679579 Free PMC article. Review.
If the ongoing therapy is contraindicated in pregnancy, then it should be switched to a compatible therapy. Prior to beginning fertility treatments in wMS, it would be reasonable to assess vitamin D serum levels, thyroid function and its antibody serum levels; start folic …
If the ongoing therapy is contraindicated in pregnancy, then it should be switched to a compatible therapy. Prior to beginning fertil …
ABO blood group and cancer.
Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB. Iodice S, et al. Eur J Cancer. 2010 Dec;46(18):3345-50. doi: 10.1016/j.ejca.2010.08.009. Eur J Cancer. 2010. PMID: 20833034 Review.
This association was confirmed by the meta-analysis of seven prior studies (summary relative risk, 0.79; 95% CI, 0.70-0.90). No association was found for endocrine pancreatic cancer or for cancer originating in other organs. ...
This association was confirmed by the meta-analysis of seven prior studies (summary relative risk, 0.79; 95% CI, 0.70-0.90). No assoc …
The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal.
Ornello R, Tiseo C, Frattale I, Perrotta G, Marini C, Pistoia F, Sacco S. Ornello R, et al. J Headache Pain. 2019 Oct 30;20(1):99. doi: 10.1186/s10194-019-1054-4. J Headache Pain. 2019. PMID: 31666008 Free PMC article. Review.
We reviewed the available literature to understand if patients with prior preventive treatment failures benefit more from the 140 mg dose than the 70 mg. ...The numerical difference between the two doses increased with the increase in the number of prior preventive …
We reviewed the available literature to understand if patients with prior preventive treatment failures benefit more from the 140 mg …
Effect of prior medical treatments on ischemic stroke severity and outcome.
Sacco S, Toni D, Bignamini AA, Zaninelli A, Gensini GF, Carolei A; SIRIO Study Group. Sacco S, et al. Funct Neurol. 2011 Jul-Sep;26(3):133-9. Funct Neurol. 2011. PMID: 22152434 Free PMC article.
Antiplatelets, antihypertensives, and statins might reduce the severity of the event or improve outcome in patients who, despite prior medical treatment, have a stroke. We evaluated, in patients who had an ischemic stroke, the effect, on stroke severity and outcome, of …
Antiplatelets, antihypertensives, and statins might reduce the severity of the event or improve outcome in patients who, despite prior
60 results